What's breaking now, across thousands of outlets.
Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
A provincial government in Nepal has legalized the use and growing of marijuana for medical purposes despite a national ban.
Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
A US biotech with a slightly different approach to the burgeoning NewCo model has raised another $115 million for its China-sourced COPD drug candidate.
Narcolepsy is a chronic neurological condition characterized by disruptions in the regulation of sleep-wake cycles. People with this condition often experience extreme sleepiness during the day and…
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new Northwestern University study.
